HELP logo

HELP
Helus Pharma Inc.

7,735
Mkt Cap
$224.66M
Volume
384,796.00
52W High
$9.83
52W Low
$4.15
PE Ratio
-0.99
HELP Fundamentals
Price
$4.55
Prev Close
$4.49
Open
$4.49
50D MA
$5.02
Beta
1.08
Avg. Volume
1.55M
EPS (Annual)
-$4.02
P/B
0.82
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Cybin (NASDAQ:HELP) Shares Up 2.7% - Should You Buy?
Cybin (NASDAQ:HELP) Shares Up 2.7% - Should You Buy...
MarketBeat
News Placeholder
More News
News Placeholder
FDA Fast-Tracks Psychedelic Research After Trump’s Executive Order — CMPS, HELP Stocks Gain
The FDA stated that this will increase support for psychedelic-based medicines for the treatment of conditions like post-traumatic stress disorder, treatment-resistant depression, and major depressive disorder.
Stocktwits
News Placeholder
Cybin Inc. (NASDAQ:HELP) Given Average Recommendation of "Buy" by Brokerages
Shares of Cybin Inc. (NASDAQ:HELP - Get Free Report) have been assigned an average recommendation of "Buy" from the six analysts that are covering the firm, Marketbeat Ratings reports. Five analysts...
MarketBeat
News Placeholder
Cybin (NASDAQ:HELP) Now Covered by TD Cowen
TD Cowen assumed coverage on shares of Cybin in a research report on Monday. They set a "buy" rating and a $8.00 price objective on the stock...
MarketBeat
News Placeholder
Cybin (NASDAQ:HELP) Shares Down 2.1% - Time to Sell?
Cybin (NASDAQ:HELP) Trading Down 2.1% - Here's What Happened...
MarketBeat
News Placeholder
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions PR Newswire VANCOUVER, BC, March 9, 2026 Issued...
PR Newswire
News Placeholder
HELP Stock Crashes On Anxiety Trial Results, But Here’s Why Jefferies Sees Up To 200% Upside
Jefferies highlighted the Phase 3 Approach trial for depression drug HLP003 as the next key catalyst for the stock.
Stocktwits
News Placeholder
Dow Futures Hold Ground After 800-Point Selloff As Oil Surge Hits Wall Street: Why MRVL, USO, COST, HELP Are Trending After-Hours
U.S. crude surged above $80 per barrel after a reported Iranian missile strike on an oil tanker.
Stocktwits
News Placeholder
Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints
Helus Pharma (Cybin) shares fall after Phase 2 anxiety drug results show symptom improvement, but pressure on the stock.read more...
Benzinga
News Placeholder
Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion
Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion PR Newswire NEW YORK, March 5, 2026 GAD...
PR Newswire
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available